PCSA vs PGR · $5.9M cap vs P/E 10, rev $45.80B
Processa Pharmaceuticals Inc (PCSA) versus Progressive Corp (PGR) — a side-by-side from cached financials, not a winner call.
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
Latest reported PCSA revenue for 2023-09-30 was $0. Net income was -$2.1M. PCSA currently screens at market cap $5.9M.
Latest reported PGR revenue for 2026-06-30 was $45.80B. Net income was $6.13B. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
PCSA currently screens at market cap $5.9M. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Not investment advice. Open the PCSA and PGR stock pages for the full models.
Not investment advice.